retatrutide type 2 diabetes trial nct A Study of (LY3437943) in Participants Without Who Have Obesity or Overweight (TRIUMPH-9) Eli Lilly retatrutide Phase 3

Association of thyrotrophin receptor antibodies with the clinical features of Graves ophthalmopathy

This review summarises the fundamental features of ferroptosis, discusses the role of VSMC ferroptosis in various vascular diseases, and highlights the emerging anti-ferroptosis therapeutic strategies, which may represent future research trends and focal points in this field

Inflammation is complex

Weight loss reduces ectopic fat deposition and risk of diabetes, but is difficult to sustain to due to compensatory increases in appetite

The dual receptor activity offers a synergistic approach, potentially resulting in more significant weight loss and improved metabolic outcomes compared to therapies targeting a single receptor pathway